Skip to main content

MaesTTRo A Non-interventional, Prospective, Multi-country Study Collecting Real-world Data on the Characteristics, Treatment Patterns, and Outcomes of Patients with Amyloid Transthyretin (ATTR) Amyloidosis

Research Grant
Duke Scholars

Awarded By

AstraZeneca AB

Start Date

December 16, 2024

End Date

December 31, 2032
 

Awarded By

AstraZeneca AB

Start Date

December 16, 2024

End Date

December 31, 2032